Specifications include, but are not limited to: The following sections have been requested for this analysis: • Market Opportunity – TAM/SAM/SOM, with emphasis on which patients are likely to actually need and benefit most from the invention as opposed to those who simply have the disease or to whom current therapy is being administered • Validation of clinical need – primary research conducted with at least three clinical experts in the field that explores demand as seen by clinicians in relation to their perception of the “problem” being solved, how that might vary by patient indications or presentation, and what evidence it would take to realize widespread adoption • Competitive Analysis – competitors, relative positioning/competitive advantages, potential partners, and how the invention compares to current clinical practice • Buying decision process – highlighting key stakeholder decision makers and likely timing to reach a purchase decision • Risks/Barriers toEntry